Product NDC: | 43063-112 |
Proprietary Name: | Dicyclomine Hydrochloride |
Non Proprietary Name: | Dicyclomine Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Dicyclomine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-112 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA085082 |
Marketing Category: | ANDA |
Start Marketing Date: | 19860619 |
Package NDC: | 43063-112-04 |
Package Description: | 4 CAPSULE in 1 BOTTLE, PLASTIC (43063-112-04) |
NDC Code | 43063-112-04 |
Proprietary Name | Dicyclomine Hydrochloride |
Package Description | 4 CAPSULE in 1 BOTTLE, PLASTIC (43063-112-04) |
Product NDC | 43063-112 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dicyclomine Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19860619 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | DICYCLOMINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |